Cascade Investment Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.34M Buy
5,486
+2,223
+68% +$518K 0.88% 31
2025
Q4
$675K Sell
3,263
-30
-0.9% -$5.93K 0.45% 54
2025
Q3
$611K Sell
3,293
-792
-19% -$136K 0.4% 57
2025
Q2
$624K Buy
4,085
+1,468
+56% +$226K 0.44% 53
2025
Q1
$434K Sell
2,617
-100
-4% -$15.6K 0.33% 68
2024
Q4
$393K Sell
2,717
-226
-8% -$35K 0.28% 79
2024
Q3
$477K Hold
2,943
0.35% 71
2024
Q2
$430K Sell
2,943
-222
-7% -$33K 0.34% 74
2024
Q1
$501K Hold
3,165
0.37% 64
2023
Q4
$496K Buy
3,165
+77
+2% +$11.8K 0.4% 63
2023
Q3
$481K Hold
3,088
0.45% 53
2023
Q2
$511K Buy
3,088
+31
+1% +$5K 0.47% 55
2023
Q1
$474K Sell
3,057
-738
-19% -$119K 0.47% 62
2022
Q4
$670K Buy
+3,795
New +$655K 0.7% 44

Other funds holding JNJ

Cascade Investment Group's JNJ Position: Q1 2026 in Review

Cascade Investment Group increased its Johnson & Johnson (JNJ) stake by 68% in Q1 2026, buying an estimated $518K and bringing the position to 5,486 shares worth $1.34M. The position accounts for 0.88% of the portfolio, ranked #31.

Cascade Investment Group first reported a position in JNJ in Q4 2022 and has held it in 14 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Cascade Investment Group held 5,486 shares of Johnson & Johnson worth $1.34M as of Q1 2026.
  • Cascade Investment Group bought 2,223 Johnson & Johnson shares in Q1 2026, an estimated $518K.
  • Johnson & Johnson made up 0.88% of Cascade Investment Group's portfolio in Q1 2026, its #31 holding.
  • Cascade Investment Group first reported a position in Johnson & Johnson in Q4 2022 and has held it in 14 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Cascade Investment Group's 13F filing for Q1 2026, filed 13 May 2026.